3.4.23.B9	Ac-PQVL-azetidine-VM	IC50: 0.25 mM	52311	
3.4.23.B9	Ac-PQVL-pipecolic acid-VM	IC50: 0.015 mM	52312	
3.4.23.B9	Ac-Pro-Glu-Val-Leu-azetidine-Val-Met	IC50: 0.250 mM	60918	
3.4.23.B9	Ac-Pro-Glu-Val-Leu-pipecolic acid-Val-Met	IC50: 0.015 mM	60917	
3.4.23.B9	Ala-Pro-Gln-Val-Leu-r-Pro-Val-Met-His-Pro	-	66627	
3.4.23.B9	Ala-Pro-Gln-Val-Sta-Val-Met-His-Pro	-	66625	
3.4.23.B9	amprenavir	-	1608	
3.4.23.B9	cerulenin	IC50: 5 mM	1438	
3.4.23.B9	Cu2+	-	19	
3.4.23.B9	DMP-323	-	33415	
3.4.23.B9	Gly-Val-Leu-Tyr-statine-Glu-Ala	IC50: 0.10 mM	60920	
3.4.23.B9	HBY-793	a compound which inhibits EIAV PR	17033	
3.4.23.B9	indinavir	-	1036	
3.4.23.B9	KH 164	modest inhibitor of MMLV PR	66624	
3.4.23.B9	LP-149	inhibitor of FIV PR	17054	
3.4.23.B9	Lys-Thr-Lys-Val-Leu-r-Val-Val-Gln-Pro-Lys	-	66628	
3.4.23.B9	Lys-Thr-Lys-Val-Sta-Val-Gln-Pro-Gly	-	66626	
3.4.23.B9	nelfinavir	-	1193	
3.4.23.B9	pepstatin A	IC50: 0.3-0.5 mM	309	
3.4.23.B9	PQV-statine-AI	IC50: 0.1 mM	52835	
3.4.23.B9	Pro-Glu-Val-statine-Ala-Leu	IC50: 0.10 mM	60919	
3.4.23.B9	ritonavir	-	996	
3.4.23.B9	saquinavir	-	997	
3.4.23.B9	UK 88.947	a compound which inhibits HIV-1PR	67005	
3.4.23.B9	YDPPAI-statine-II	IC50: 0.0005 mM	13481	
3.4.23.B9	YDPPAI-statine-II	-	13481	
3.4.23.B9	YDPPAI-statine-II	strong inhibition, IC50: 0.0005 mM	13481